Home › Osteosarcoma › Oklahoma › Oklahoma City
Osteosarcoma clinical trials in Oklahoma City, OK
3 studies for Osteosarcoma are looking for participants at sites in and around Oklahoma City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
RecruitingPhase 1
- University Of Oklahoma Health Sciences Center, Oklahoma City
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RecruitingPhase 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- University of Oklahoma Health Sciences Center, Oklahoma City
Osteosarcoma trials in other cities
- St. Louis, MO10 studies
- Memphis, TN10 studies
- Atlanta, GA10 studies
- Boston, MA9 studies
- Houston, TX9 studies
- Birmingham, AL7 studies
- Cincinnati, OH7 studies
- Mountain View, CA7 studies
- Los Angeles, CA7 studies
- Chicago, IL7 studies
- Dallas, TX6 studies
- Tampa, FL6 studies
Other studies in Oklahoma City
- Non-Small Cell Lung Cancer32 studies
- Ovarian Cancer29 studies
- Endometrial Cancer28 studies
- Colorectal Cancer22 studies
- Prostate Cancer22 studies
- Lung Cancer20 studies
- Breast Cancer18 studies
- Metastatic Cancer17 studies
- Acute Myeloid Leukemia15 studies
- Cancer (all types)15 studies
- Head and Neck Squamous Cell Carcinoma14 studies
- Bladder Cancer11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.